3.24
price up icon2.86%   0.09
after-market Dopo l'orario di chiusura: 3.14 -0.10 -3.09%
loading
Precedente Chiudi:
$3.15
Aprire:
$3.36
Volume 24 ore:
970.22K
Relative Volume:
1.51
Capitalizzazione di mercato:
$325.94M
Reddito:
-
Utile/perdita netta:
$-60.14M
Rapporto P/E:
-4.5666
EPS:
-0.7095
Flusso di cassa netto:
$-68.17M
1 W Prestazione:
+16.55%
1M Prestazione:
-1.52%
6M Prestazione:
+66.15%
1 anno Prestazione:
+9.83%
Intervallo 1D:
Value
$3.13
$3.39
Intervallo di 1 settimana:
Value
$2.54
$3.80
Portata 52W:
Value
$1.4299
$4.00

Ac Immune Sa Stock (ACIU) Company Profile

Name
Nome
Ac Immune Sa
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
172
Name
Cinguettio
@AC_Immune_SA
Name
Prossima data di guadagno
2025-04-28
Name
Ultimi documenti SEC
Name
ACIU's Discussions on Twitter

Confronta ACIU con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ACIU
Ac Immune Sa
3.24 316.89M 0 -60.14M -68.17M -0.7095
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.71 114.69B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
752.62 77.91B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
850.95 54.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
391.50 52.52B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
196.92 42.02B 447.02M -1.18B -906.14M -6.1812

Ac Immune Sa Stock (ACIU) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-05-31 Iniziato BTIG Research Buy
2019-02-01 Downgrade UBS Buy → Neutral
2019-01-04 Iniziato UBS Buy
2018-04-05 Iniziato H.C. Wainwright Buy
2018-03-23 Downgrade Credit Suisse Outperform → Neutral
2016-10-18 Iniziato Credit Suisse Outperform
2016-10-18 Iniziato Jefferies Buy
2016-10-18 Iniziato Leerink Partners Outperform
Mostra tutto

Ac Immune Sa Borsa (ACIU) Ultime notizie

pulisher
02:50 AM

AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD - Seeking Alpha

02:50 AM
pulisher
Dec 12, 2025

AC Immune SA (ACIU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 12, 2025
pulisher
Dec 12, 2025

Performance Recap: Will AC Immune SA stock outperform growth indexesJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - moha.gov.vn

Dec 12, 2025
pulisher
Dec 12, 2025

Aug Macro: Will AC Immune SA IMR stock outperform value peers2025 Technical Overview & Precise Swing Trade Alerts - moha.gov.vn

Dec 12, 2025
pulisher
Dec 12, 2025

AC Immune Perks Up On Positive Parkinson’s Data - Citeline News & Insights

Dec 12, 2025
pulisher
Dec 12, 2025

AC Immune reports promising phase 2 results for Parkinson’s therapy - MSN

Dec 12, 2025
pulisher
Dec 11, 2025

AC Immune’s Parkinson’s vaccine advances on promising biomarker profile - BioCentury

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune Simulates Curiosity in Neurodegenerative Fight with Global Conference Plans - StocksToTrade

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune (ACIU) Stock: Surges as ACI-7104.056 Shows Potential in Early Parkinson’s Disease - parameter.io

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - Benzinga

Dec 11, 2025
pulisher
Dec 11, 2025

Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results - TipRanks

Dec 11, 2025
pulisher
Dec 11, 2025

Why Is AC Immune Stock Up Over 23% Today? - Asianet Newsable

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune SA: Navigating Market Momentum - timothysykes.com

Dec 11, 2025
pulisher
Dec 11, 2025

ACIU Surges 30% on Positive Parkinson's Therapy Trial Results - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results - TipRanks

Dec 11, 2025
pulisher
Dec 11, 2025

ACIU: ACI-7104.056 shows promise in slowing Parkinson's progression with strong safety and efficacy - TradingView

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune’s Parkinson’s treatment shows promise in slowing disease - Investing.com

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune surges on Parkinson’s drug data (ACIU:NASDAQ) - Seeking Alpha

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune (ACIU) Reports Encouraging Phase 2 Results for Parkins - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

Ac Immune shares climb 32.6% premarket after co reports positive trial data for Parkinson's disease therapy - marketscreener.com

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune stock rises after positive Parkinson’s disease trial data - Investing.com India

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy - TipRanks

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune Reports Positive Interim Phase 2 Data for ACI-7104.056 Indicating Potential to Slow Parkinson's Disease Progression - Quiver Quantitative

Dec 11, 2025
pulisher
Dec 11, 2025

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease - GlobeNewswire Inc.

Dec 11, 2025
pulisher
Dec 10, 2025

AC Immune SA's (NASDAQ:ACIU) stock price dropped 11% last week; retail investors would not be happy - simplywall.st

Dec 10, 2025
pulisher
Dec 09, 2025

Sentiment Watch: Will AC Immune SA stock deliver long term returns - moha.gov.vn

Dec 09, 2025
pulisher
Dec 06, 2025

Aug Reactions: Why ETFs are accumulating AC Immune SA IMR stockEarnings Risk Summary & Daily Stock Trend Watchlist - BỘ NỘI VỤ

Dec 06, 2025
pulisher
Dec 05, 2025

Quarterly Risk: Why analysts upgrade AC Immune SA stock2025 Sector Review & Fast Momentum Stock Entry Tips - BỘ NỘI VỤ

Dec 05, 2025
pulisher
Dec 05, 2025

How AC Immune SA (IMR) stock reacts to weak economyVolume Spike & Weekly High Potential Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is AC Immune SA (IMR) stock a top dividend aristocrat candidate2025 Short Interest & Reliable Price Action Trade Plans - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

How big funds are accumulating AC Immune SA (IMR) stock2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Will AC Immune SA (IMR) stock profit from AI boomCPI Data & Comprehensive Market Scan Insights - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Why AC Immune SA (IMR) stock trades below fair valueQuarterly Market Review & Capital Efficiency Focused Strategies - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How geopolitical risks impact AC Immune SA (IMR) stock2025 Volume Leaders & Fast Entry Momentum Alerts - Newser

Dec 04, 2025
pulisher
Dec 02, 2025

Will AC Immune SA (IMR) stock benefit from commodity supercycleWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

What analysts say about AC Immune SA IMR stockShort Selling Opportunities & Free Explosive Wealth Accumulation - earlytimes.in

Nov 30, 2025
pulisher
Nov 26, 2025

Adversity is less terrifying than hope: AC Immune SA (ACIU) - Setenews

Nov 26, 2025
pulisher
Nov 21, 2025

Is AC Immune SA stock a top pick in earnings seasonQuarterly Trade Report & Expert Approved Momentum Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why millennials buy AC Immune SA (IMR) stockJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will AC Immune SA stock recover faster than peersJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Is AC Immune SA (IMR) stock positioned for digital growth eraJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Why analysts remain bullish on AC Immune SA stockGDP Growth & Pattern Based Trade Signal System - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can AC Immune SA stock resist sector downturnsEarnings Risk Summary & Expert Curated Trade Setup Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Signal strength of AC Immune SA stock in tech scannersBuy Signal & Momentum Based Trading Signals - newser.com

Nov 19, 2025

Ac Immune Sa Azioni (ACIU) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$38.53
price up icon 0.36%
$98.64
price up icon 3.39%
$31.57
price up icon 0.83%
$93.81
price down icon 1.05%
biotechnology ONC
$310.67
price down icon 2.63%
$196.92
price down icon 0.05%
Capitalizzazione:     |  Volume (24 ore):